The PGY-1 Residency Experience at WFH
PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
The residency program at WFH began in July 2011, receiving full accreditation from ASHP in April 2013. The PGY-1 pharmacy residency prepares its graduates to assume positions as patient care clinicians, to serve as adjunct faculty for a college of pharmacy with the optional teaching certificate program, to become a board certified pharmacotherapy specialist, or to pursue a second year postgraduate training in a focused area of practice.
The resident will be an active member of the healthcare team with opportunities to influence medication use and safety practices. The resident will have opportunities to be involved with teaching pharmacy students, formulary management, policy development, antimicrobial stewardship, residency project presentation at the annual ASHP Midyear Clinical Meeting and the Florida Residency Conference.
Our supportive, close-knit workplace means a friendly, caring, patient-centered environment with one-on-one daily interactions with preceptors and the medical staff. Each resident has his/her own personal desk in a spacious office. Residents also receive a personal laptop with remote access to all of the necessary clinical tools a resident needs. The PGY-1 program at West Florida Hospital offers flexibility, while providing a strong foundation in all areas of pharmacy practice.
It is the goal of the PGY-1 pharmacy practice residency at WFH to provide the following outcomes to all residents completing the program:
- Confidence to work autonomously as a clinical pharmacist and collaborate in interdisciplinary groups as part of the healthcare team
- Competence to provide education to other health care professionals in various settings
- Leadership skills to work within any healthcare system
- Awareness and initiative to lead medication safety efforts throughout the health system
- Enhanced professionalism and marketable job skills to further a career in the practice of clinical pharmacy
Duration/Type: 12 months/Residency
Number of Positions: 3
Application Deadline: The 6th of January, every year
Start Date: The end of June
Estimated Stipend: $48,000
Interview Required: Yes
- 16 days of paid time off
- Full dental, health, and vision coverage
- Educational and professional travel allowances
- Life insurance
Longitudinal Learning Experiences:
- Infectious Diseases
- Pharmacy Administration
- Research Project
Core Learning Experiences:
- Adult Internal Medicine
- Critical Care
- Consult Service
Elective Learning Experiences:
- Antimicrobial Stewardship
- Critical Care II
- Pediatrics II
- Rehabilitative Medicine
Our residency program utilizes Pharmacy Online Residency Centralized Application Service (PhORCAS). Access the PhORCAS portal. In order to apply for the PGY-1 pharmacy residency at WFH, we do not require anything beyond the standard PhORCAS requirements. As part of the selection process, an interview will be required. Finally, incoming residents must be eligible for licensure or already licensed as a pharmacist in the State of Florida.
Residency Program Director
Dr. Melissa Holloway earned her Doctor of Pharmacy in 2014 from Belmont University College of Pharmacy in Nashville, TN. After receiving her PharmD, she completed a post-doctoral PGY-1 pharmacy residency at West Florida Hospital in June of 2015. From there she stayed on as a full-time clinical pharmacist involved in precepting residents. In order to actively pursue antimicrobial stewardship activities at WFH, Dr. Holloway became a board-certified infectious diseases pharmacist (BCIDP) and earned MAD-ID (Making a Difference in Infectious Diseases) certification from the Advanced Antimicrobial Stewardship Training Program provided by MAD-ID and the National Foundation for Infectious Diseases (NFID). Dr. Holloway has been a prominent member of the Antimicrobial Management Program at WFH and in 2018 she served on HCA’s Clinical Pharmacy Advisory Board. After training for several years under the previous Residency Program Director, Ernie Cyr, she became the PGY-1 residency director in March 2019 while continuing to provide patient care as a clinical pharmacist.
Melissa Holloway, PharmD, BCPS, BCIDP
Advanced Clinical Pharmacist / PGY-1 Pharmacy Residency Program Director
West Florida Hospital
8383 North Davis Highway
Pensacola, FL 32514
Dr. Gabrielle Arceo
Dr. Gabrielle Arceo is originally from Jackson, Mississippi. She earned her Doctorate of Pharmacy from the University of Mississippi School of Pharmacy after completing her Bachelor of Science in Pharmaceutical Sciences at the University of Mississippi – Ole Miss in Oxford, MS. Her professional interests include cardiology, pediatrics, and ambulatory care. Upon completion of her PGY-1 Pharmacy Residency, Dr. Arceo intends to work as a clinical pharmacist and obtain board certification. Her future plans also include practicing at an academic medical center with opportunities to precept students and residents.
Dr. Laura Comalander
Dr. Laura Comalander is originally from Fairhope, AL. She received her Doctorate of Pharmacy from Auburn University Harrison School of Pharmacy. Her clinical interests include emergency medicine, critical care, and internal medicine. Upon completion of her PGY-1 residency, Dr. Comalander plans to pursue a career as a clinical pharmacist.
Dr. Caitlin Sacco
Dr. Caitlin Sacco is a native of Pensacola, FL. She earned her Doctorate of Pharmacy from Belmont University in Nashville after completing a Bachelor of Science in Biology at Mississippi State University in Starkville, MS. Her clinical interests include psychiatry and infectious diseases. Upon completion of her PGY1 residency, Dr. Sacco plans to pursue a clinical pharmacist role locally.